Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-10-19
1993-03-02
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549465, A61K 3134, A61K 31557, C07D307937
Patent
active
051909731
ABSTRACT:
The invention concerns 20-alkyl-7-oxoprostacyclin derivatives of general Formula I ##STR1## wherein R.sub.1 is the residue OR.sub.3 where R.sub.3 means hydrogen or alkyl of 1-10 carbon atoms optionally substituted by halogen, phenyl, C.sub.1 -C.sub.4 -alkoxy or C.sub.1 -C.sub.4 -dialkylamino; cycloalkyl, aryl or a heterocyclic residue, or the residue NHR.sub.4 where R.sub.4 means hydrogen or an alkanoyl or alkanesulfonyl residue of respectively 1-10 carbon atoms,
REFERENCES:
patent: 4364950 (1982-12-01), Shuballa et al.
patent: 4466969 (1984-08-01), Nicholson et al.
van Dorp et al., Prostaglandins, vol. 16(6), pp. 953-956.
Haberey Martin
Nickolson Robert
Stuerzebecher Claus S.
Vorbrueggen Helmut
Dentz Bernard
Schering Aktiengesellschaft
LandOfFree
20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-126936